Exel Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exel Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exel Research Today - Breaking & Trending Today

Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

Published: October 30, 2023

- Successfully met primary endpoint; brilaroxazine 50 mg delivered a statistically significant and clinically meaningful 10.1-point reduction in Positive and Negative Syndrome Scale total score vs....

Source: marketscreener.com

Related Topics:

United StatesLarry EreshefskyBruce MackleCenexel ResearchSecurities ExchangeReviva PharmaceuticalsClinical SciencesExchange CommissionGlobenewswire IncLifesci AdvisorsReviva Pharmaceuticals Holdings IncNegative Syndrome ScalePharmaceuticals HoldingsChief Scientific OfficerExel ResearchConference CallNegative Symptoms AssessmentOrphan Drug DesignationLooking StatementsSecurities ActSecurities Exchange ActPrivate Securities Litigation Reform ActAnnual ReportRelations ContactSci Advisors